1.25 USD
↘ 0.08 (6.02%)AT CLOSE (11:59 AM EDT)
GeoVax Labs, Inc. New
GOVXNASDAQ • USD
1.24
↗ 0.01 (1.12%)
POST MARKET (AS OF 04:51 PM EDT)
Post Market
AS OF 04:51 PM EDT
1.24
↗ 0.01 (1.12%)
Market: OPEN
Open?$1.31
High?$1.33
Low?$1.24
Prev. Close?$1.33
Volume?87.0K
Avg. Volume?66.5K
VWAP?$1.29
Rel. Volume?1.31x
Bid / Ask
Bid?$1.24 × 100
Ask?$1.26 × 100
Spread?$0.02
Midpoint?$1.25
Valuation & Ratios
Market Cap?3.0M
Shares Out?1.8M
Float?43.1M
Float %?99.4%
P/E Ratio?N/A
P/B Ratio?0.60
EPS?-$11.38
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.57Strong
Quick Ratio?3.57Strong
Cash Ratio?2.75Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?0.60CHEAP▾
P/S?0.88CHEAP▾
P/FCF?N/A▾
EV/EBITDA?0.1CHEAP▾
EV/Sales?-0.61CHEAP▾
Returns & Efficiency
ROE?-515.8%WEAK▾
ROA?-376.0%WEAK▾
Cash Flow & Enterprise
FCF?$-24293355
Enterprise Value?$-2051640
Related Companies
Loading...
News
Profile
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
Address
1900 LAKE PARK DRIVE
SMYRNA, GA 30080
Phone: 678-384-7220
SMYRNA, GA 30080
Phone: 678-384-7220